CEO signs a restricted stock award agreement
On May 16, 2025, President and CEO Todd DeSantis entered into an award agreement granting him 200,000 restricted shares of common stock, following his appointment.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
On May 16, 2025, President and CEO Todd DeSantis entered into an award agreement granting him 200,000 restricted shares of common stock, following his appointment.
Kairos Pharma's lead candidate ENV-105 won the Cancer Immunology Solution award for targeting drug resistance. The company announced positive interim efficacy data from its Phase 2…
Aptevo successfully refined mipletamig's priming dose to reduce patient infusion reactions. This improves tolerability for frontline AML patients, strengthening the drug's profile …
The RealReal board strengthens governance by appointing former Match Group CEO Sharmistha Dubey. The addition of a veteran tech executive supports the company's strategy to scale i…
Joe Lovechio resigned as CFO to pursue other opportunities, and Jeffrey Watorek has been appointed interim CFO. The change is effective November 20, 2026.
Evommune will discuss the in-licensing of EVO570 at a webcast scheduled for Thursday, highlighting progress in its immunology pipeline, a key area for biotechnology investors.
The presentation outlines management's forecast, outlook, and strategic goals for the remainder of the fiscal year.
Regions Financial Corporation presented comprehensive investor strategy demonstrating strong growth in core markets and disciplined capital allocation while emphasizing long-term s…
Old National Bancorp released a slide deck highlighting its third quarter 2026 investment thesis, reiterating key aspects of its long-term strategy and outlining future business ob…
Independent Bank Corp. filed an investor presentation outlining company highlights, board updates, and guidance for the year. The 8-K highlights the company's stability as a Fed me…
Kim Cocklin is retiring as Chairman effective at the 2027 annual meeting and could be succeeded by CEO J. Kevin Akers, shifting the leadership structure.
Universal Corporation appointed Gregory R. Friedman to its Board of Directors after more than 30 years of financial and operational experience, effective November 4, 2026.
Thunder Mountain Gold appointed veteran mining executive Ron Clayton to its Board of Directors on October 1. Clayton brings 40 years of industry experience with companies such as i…
The company named Dr. Steven Osterberg as Senior Vice President of Exploration and stated that Ron Espell has stepped down as Chief Operating Officer. This leadership change unders…
German American Bancorp, the 5th largest bank in Indiana, presented its asset profile and strategy for growth at the Hovde Group Financial Services Conference, highlighting strong …
Creatd appointed Claudia Albelais CFO and Chelsea Pullano to its board ahead of an exchange listing, reflecting strengthened governance and financial operations.
Ensysce Biosciences amended Dr. Lynn Kirkpatrick's employment and title to Chief Operating Officer effective January 1, 2027. Market relevance is null as no financial guidance was …
UFP Industries appointed Scott Worthington, President of UFP Packaging, as Vice President of Investor Relations, succeeding Stanley Elliott who accepted a role outside the company.…
Flowers Foods elected Shaun Mara and Ken Plunk as new independent directors to its board effective Nov. 18, 2026, expanding the board to 10 members and including them on the audit …
Labcorp announced Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10. This leadership engagement provides insight into the company…